SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689375-24-000047
Filing Date
2024-08-13
Accepted
2024-08-13 07:14:12
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trda-20240630.htm   iXBRL 10-Q 1578947
2 EX-10.3 entrada-secondamendedandre.htm EX-10.3 14361
3 EX-31.1 trda-20240630x10qex311.htm EX-31.1 10864
4 EX-31.2 trda-20240630x10qex312.htm EX-31.2 10887
5 EX-32.1 trda-20240630x10qex321.htm EX-32.1 7219
  Complete submission text file 0001689375-24-000047.txt   6108706

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20240630.xsd EX-101.SCH 34066
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trda-20240630_cal.xml EX-101.CAL 59393
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trda-20240630_def.xml EX-101.DEF 166953
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20240630_lab.xml EX-101.LAB 514054
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20240630_pre.xml EX-101.PRE 352865
72 EXTRACTED XBRL INSTANCE DOCUMENT trda-20240630_htm.xml XML 650386
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40969 | Film No.: 241198754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)